Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00520273 · ClinicalTrials.gov registry record · NA
A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA
A NA study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- NA
- Development phase
- 100,000
- Enrollment target
NCT00520273: Completed NA study, sponsored by Hoffmann-La Roche.
NCT00520273 is a NA study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 100,000 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (7033% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00520273, a NA study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- NA
- Development phase
- 100,000 participants
- Enrollment target
Study Summary
This study will evaluate the specificity of the cobas TaqScreen MPX Test for the simultaneous detection of HBV DNA, HCV RNA and HIV-1 Group M in a minimum of 100,000 individual donor samples in 96-unit pools.
Interventions
- DEVICE cobas s 201 TaqScreen MPX Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2007-08 |
| Est. Completion | 2007-10 |
| Phase | NA |
What the finished NCT00520273 record still lists
NCT00520273 is an interventional study that assigns participants to a tested intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (7033% higher).
The record links to 0 conditions, and to 1 intervention - of which cobas s 201 TaqScreen MPX Test is the first listed.
NCT00520273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00520273 about?
NCT00520273 is a clinical study titled "A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA". This study will evaluate the specificity of the cobas TaqScreen MPX Test for the simultaneous detection of HBV DNA, HCV RNA and HIV-1 Group M in a minimum of 100,000 individual donor samples in 96-unit pools.
What is the current status of trial NCT00520273?
This trial is currently completed. It is a NA study. The enrollment target is 100,000 participants. The study started on 2007-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00520273?
The interventions under investigation include: cobas s 201 TaqScreen MPX Test (DEVICE).
Who is sponsoring clinical trial NCT00520273?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00520273's enrollment target sits among peer trials
100,000 3rd of 2000 higher than 1,998 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia